
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 29, 2024
Language: Английский
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 29, 2024
Language: Английский
Journal for Research in Applied Sciences and Biotechnology, Journal Year: 2025, Volume and Issue: 4(1), P. 132 - 141
Published: Feb. 28, 2025
Chronic renal disease is defined as the presence of kidney damage or impaired function over a period at least three months, regardless origin condition. Numerous factors, including oxidative stress, inflammation, and cell death, are frequently responsible for acute chronic injury, which significant issue in field global health. Because crucial functions that they play, NF-κB PI3K/Akt signaling pathways potential therapeutic targets. These pathogenic processes mediated by these pathways. cinnamonaldehyde, naturally occurring bioactive component, has demonstrated encouraging nephroprotective properties. properties attributed to fact it contains anti-inflammatory, antioxidant, anti-apoptotic The purpose this review investigate molecular role cinnamaldehyde preventing modulating Within article, we examine involved highlight treatment disease. Although preclinical studies have protective effects, additional research, clinical trials, required validate its safety, effectiveness, uses management illness people.
Language: Английский
Citations
0Medical Oncology, Journal Year: 2025, Volume and Issue: 42(4)
Published: March 12, 2025
Language: Английский
Citations
0Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16
Published: March 19, 2025
Cancer is one of the leading causes death worldwide. Many therapies are being used to treat this disease, however, new treatments now implemented, since they not always effective and their secondary effects represent main reasons for cancer patients’ loss life quality during progression disease. In scenario, Ocoxin a mixture plant extracts, amino acids, vitamins minerals, known its antioxidant, anti-inflammatory immunoregulatory properties, which has shown exert antitumor in many cancers. The aim study elucidate mechanism action compound colorectal cancer, triple negative breast pancreatic prostate cancer. Analyses performed through RNA sequencing revealed that effect appears be alteration cell metabolism, especially inducing process ferroptosis. Nevertheless, modulation cycle was also remarkable. altered 13 genes common all four cancers were only associated metabolism but involved integrated stress response unfolded protein response, suggesting induction several pathways. Although mechanisms vary according type highlights potential as an adjunctive treatment improve outcomes therapy.
Language: Английский
Citations
0Journal of Chemotherapy, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 18
Published: April 15, 2025
AbstractCombination chemotherapy using liposomes offers a promising approach to overcome resistance and minimize side effects in breast cancer treatment. This study explores the synergistic of all-trans-retinoic acid (ATRA) cinnamaldehyde (CA) combined with cisplatin (CPT) MDA-MB-231 cells. The liposomal formulation, CPT_ATRA_CA, significantly reduced cell proliferation 25.9 ± 2.8% compared controls effectively inhibited angiogenesis. Additionally, it induced apoptosis, as demonstrated by flow cytometry, DAPI staining, an elevated Bax/Bcl-2 gene expression ratio. Computational analysis via molecular docking dynamics simulation revealed that ATRA exhibited highest binding affinity for angiogenin (ANG) energy -106.072 kcal/mol. Experimental results, corroborated computational data, highlight potent anti-tumor this drug trio. These findings suggest delivery ATRA, CA, CPT could enhance therapeutic outcomes targeting multiple pathways synergistically.
Language: Английский
Citations
0International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(16), P. 9026 - 9026
Published: Aug. 20, 2024
Colorectal cancer (CRC) continues to be a significant contributor global morbidity and mortality. Emerging evidence indicates that disturbances in gut microbial composition, the formation of reactive oxygen species (ROS), resulting inflammation can lead DNA damage, driving pathogenesis progression CRC. Notably, bacterial metabolites either protect against or contribute oxidative stress by modulating activity antioxidant enzymes influencing signaling pathways govern ROS-induced inflammation. Additionally, microbiota byproducts, when supplemented through probiotics, affect tumor microenvironments enhance treatment efficacy selectively mediate destruction CRC cells. This review aims discuss mechanisms which taxonomical shifts related such as short-chain fatty acids, secondary bile trimethylamine-N-oxide influence ROS concentrations safeguard promote onset inflammation-mediated we focus on role probiotic ROS-mediated both status inflammation, Nrf2-Keap1, NF-κB, NLRP3 mitigate carcinogenesis. Overall, deeper understanding may aid delaying preventing offer new avenues for adjunct, CRC-specific therapeutic interventions immunotherapy.
Language: Английский
Citations
3Journal of Functional Foods, Journal Year: 2024, Volume and Issue: 122, P. 106545 - 106545
Published: Nov. 1, 2024
Language: Английский
Citations
1Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 29, 2024
Language: Английский
Citations
0